Mon, September 11, 2017
Fri, September 8, 2017
Thu, September 7, 2017
Wed, September 6, 2017
Tue, September 5, 2017

Gena Wang Initiated (SRPT) at Hold and Held Target at $46 on, Sep 7th, 2017

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. -hold-and-held-target-at-46-on-sep-7th-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Gena Wang of Barclays, Initiated "Sarepta Therapeutics, Inc." (SRPT) at Hold and Held Target at $46 on, Sep 7th, 2017.

Gena has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, all agrees with Gena's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $33 on, Thursday, July 20th, 2017